Sentinel Lymph Node Mapping of Oral Cancer Using Near-Infrared Fluorescence Imaging

NACompletedINTERVENTIONAL
Enrollment

1

Participants

Timeline

Start Date

May 31, 2015

Primary Completion Date

January 8, 2024

Study Completion Date

January 8, 2024

Conditions
Head and Neck Neoplasms
Interventions
PROCEDURE

Sentinel lymph node mapping

Thirty (30) patients will be enrolled under informed consent based upon their medical diagnosis, planned surgical procedures, and suitability for the procedure. During the study, patients will receive injections of ICG and will be imaged using a commercial NIR imaging system (Pinpoint, Novadaq, Waterloo ON). After the study, patients will continue with their planned management.

DRUG

Indocyanine Green (ICG)

DEVICE

near-infrared fluorescence (NIR) imaging (Pinpoint, Novadaq, Waterloo)

Trial Locations (1)

M5G 2C4

University Health Network, Toronto

All Listed Sponsors
lead

University Health Network, Toronto

OTHER

NCT02478138 - Sentinel Lymph Node Mapping of Oral Cancer Using Near-Infrared Fluorescence Imaging | Biotech Hunter | Biotech Hunter